A
605116
vs
S
Shanghai Composite
Over the past 12 months, Aurisco Pharmaceutical Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +48% compared to the Shanghai Composite's +27% growth.
Stocks Performance
605116 vs Shanghai Composite
Performance Gap
605116 vs Shanghai Composite
Performance By Year
605116 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Aurisco Pharmaceutical Co Ltd
Glance View
Aurisco Pharmaceutical Co Ltd, a notable player in the world of pharmaceuticals, has carved a distinct niche for itself with its focus on the development and manufacturing of specialized active pharmaceutical ingredients (APIs). Founded in China, the company operates in a sector driven by intricate processes and stringent regulations, where high-quality production is paramount. Aurisco has established itself by continuously investing in research and development, ensuring that its production capabilities remain at the forefront of innovation. Its commitment to excellence is reflected in its comprehensive portfolio, which caters to a wide range of therapeutic areas, addressing global healthcare needs with precision and efficiency. Aurisco's business model revolves around not just the production but also the value-added features of customization and compliance. By engaging in contract manufacturing and developing APIs for major pharmaceutical firms worldwide, Aurisco navigates a landscape that balances intricate scientific processes with the practical demands of global distribution. The company's revenue is bolstered by its ability to meet international standards, allowing it to forge crucial partnerships across continents. Aurisco’s adeptness at managing complex supply chains and its strategic positioning within the pharmaceutical sector enable it to capitalize on growth opportunities, reinforcing its status as a vital cog in the global healthcare machinery.
